A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
Clinical trial NCT03876925 · TERMINATED
Trial details
- NCT number
- NCT03876925
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2020-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.